文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

新型冠状病毒肺炎疫情期间体外膜肺氧合院际转运研究:基于6例重症H1N1流感病毒肺炎体外膜肺氧合转运经验

[Study on the extracorporeal membrane oxygenation inter-hospital transport during coronavirus disease 2019 epidemic: based on the transport experience of 6 cases of severe H1N1 influenza virus pneumonia on extracorporeal membrane oxygenation].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论具备经验丰富的ECMO转运团队、良好转运设备、全面防护措施、合理转运流程和完善应急预案时,使用ECMO转运COVID-19患者是安全的。

该回顾性分析纳入2018年10月至2019年12月皖南医学院第一附属医院收治的6例重症H1N1流感病毒肺炎并实施ECMO的患者,均由当地医院建立ECMO后经ECMO转运团队转入该院ICU。转运距离11~197 km,平均(93.8±58.6)km;转运时间30~150分钟,平均(79.2±40.6)分钟。2例患者转运过程中出现ECMO流量和SpO2下降,主要原因为容量不足,经液体复苏和体位调整后改善;所有患者SpO2维持在0.93以上。6例患者均存活出院,ECMO辅助时间4~9天,平均(6.5±1.5)天;机械通气时间7~24天,中位数10.0(8.0,14.5)天;医务人员无H1N1传播。作者总结个人防护、转运流程与设备、团队协作、转运中监测和质量控制等方面经验,为COVID-19疫情期间使用ECMO的院际转运提供参考。

要点

  • 6例重症H1N1流感病毒肺炎患者在当地医院建立ECMO后由ECMO转运团队转入皖南医学院第一附属医院ICU,转运距离11~197 km,平均(93.8±58.6)km。
  • 转运时间30~150分钟,平均(79.2±40.6)分钟;2例转运中出现ECMO流量和SpO2下降,主要原因为容量不足,经液体复苏和体位调整后改善。
  • 所有患者转运中SpO2维持在0.93以上,6例均存活出院;ECMO辅助时间4~9天,平均(6.5±1.5)天;机械通气时间7~24天,中位数10.0(8.0,14.5)天。
  • 医务人员无H1N1传播;作者认为取得良好疗效的主要经验包括选择合适的ECMO时机和模式、完好的转运车辆和设备、转运中有效管理呼吸和循环以避免呼吸机相关性肺损伤(VALI)和严重低氧血症、转运团队有适当空间快速处理各种危急情况以及个人防护避免感染。
  • 作者结论认为,具备经验丰富的ECMO转运团队、良好转运设备、全面防护措施、合理转运流程和完善应急预案时,使用ECMO转运COVID-19患者是安全的。

适用人群与场景

  • 2018年10月至2019年12月皖南医学院第一附属医院收治的6例重症H1N1流感病毒肺炎并实施ECMO的患者,均在当地医院建立ECMO后由ECMO转运团队转入该院ICU。

处置流程与药物剂量

  • 在当地医院建立ECMO后,由ECMO转运团队将患者转运至皖南医学院第一附属医院ICU。
  • 转运中2例患者出现ECMO流量和SpO2下降,主要原因为容量不足,经液体复苏和体位调整后改善。
  • 作者总结的经验包括:选择合适的ECMO时机和模式;保持转运车辆和设备完好以减少或避免机械并发症;转运中有效管理呼吸和循环以避免呼吸机相关性肺损伤(VALI)和严重低氧血症;转运团队有适当空间快速处理各种危急情况;做好个人防护避免感染。

红旗征与不能漏的情况

  • 转运过程中出现ECMO流量和SpO2下降,主要原因为容量不足,经液体复苏和体位调整后改善。

研究设计与关键结果

  • 回顾性分析6例重症H1N1流感病毒肺炎并实施ECMO的患者,均由当地医院建立ECMO后经ECMO转运团队转入皖南医学院第一附属医院ICU。
  • 转运距离11~197 km,平均(93.8±58.6)km;转运时间30~150分钟,平均(79.2±40.6)分钟。
  • 2例患者转运过程中出现ECMO流量和SpO2下降,主要原因为容量不足,经液体复苏和体位调整后改善;所有患者SpO2维持在0.93以上。
  • 6例患者均存活出院;ECMO辅助时间4~9天,平均(6.5±1.5)天;机械通气时间7~24天,中位数10.0(8.0,14.5)天;医务人员无H1N1传播。

证据类型、等级与局限

  • 证据类型:回顾性分析,样本量6例。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,具备经验丰富的ECMO转运团队、良好转运设备、全面防护措施、合理转运流程和完善应急预案时,使用ECMO转运COVID-19患者是安全的。
  • 作者总结的经验包括:选择合适的ECMO时机和模式;保持转运车辆和设备完好以减少或避免机械并发症;转运中有效管理呼吸和循环以避免呼吸机相关性肺损伤(VALI)和严重低氧血症;转运团队有适当空间快速处理各种危急情况;做好个人防护避免感染。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To provide a reference for extracorporeal membrane oxygenation (ECMO) inter-hospital transport during coronavirus disease 2019 (COVID-19), based on the transport experience of 6 patients with severe H1N1 influenza virus pneumonia using ECMO.

METHODS: Clinical data of patients with severe H1N1 influenza virus pneumonia implemented by ECMO in the First Affiliated Hospital of Wannan Medical College from October 2018 to December 2019 were retrospective analyzed, including general information, ECMO transport distance, time, clinical parameters before and after ECMO, including the patients' oxygenation index (PaO2/FiO2), respiratory rate (RR), pulse blood oxygen saturation (SpO2), arterial blood carbon dioxide partial pressure (PaCO2), and pH value, various complications during transport, mechanical ventilation time, patients' prognosis and other indicators. Experience from the aspects of personal protection, transport process and equipment, team cooperation, mid-transit monitoring, quality control, etc., was summarized to provide suggestions for patients with severe COVID-19 using ECMO during inter-hospital transport and protection.

RESULTS: A total of 6 patients with severe H1N1 influenza virus pneumonia were transported on ECMO. All patients were transported to the intensive care unit (ICU) of the First Affiliated Hospital of Wannan Medical College by the ECMO transport team after the establishment of ECMO in the local hospital. The transfer distance was 11 to 197 km, with an average of (93.8±58.6) km; the transfer time was 30 to 150 minutes, with an average of (79.2±40.6) minutes. Two patients experienced a drop in ECMO flow and SpO2 during the process, and the main reason was insufficient volume, which was improved after fluid resuscitation and posture adjustment. All patients maintained SpO2 above 0.93. Six patients survived and were discharged. ECMO assisted time was 4-9 days, with an average of (6.5±1.5) days; mechanical ventilation time was 7-24 days, and median time was 10.0 (8.0, 14.5) days. No H1N1 transmission occurred in medical personnel. To achieve good therapeutic effect, the main experience was to choose the proper timing and mode of ECMO; intact transportation vehicles and equipment to reduce or avoid mechanical complications; the effective management of respiration and circulation during the transportation to avoid ventilation-associated lung injury (VALI) and serious hypoxemia; the appropriate space for the transfer team to quickly handle various critical situations; and personal protection to avoid infection.

CONCLUSIONS: With an experienced ECMO transport team, good transport equipment, comprehensive protection measures, reasonable transport procedures, and a perfect emergency plan, it is safe to use ECMO transport for COVID-19 patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Xu Q, Jiang X, Wang T, et al. [Study on the extracorporeal membrane oxygenation inter-hospital transport during coronavirus disease 2019 epidemic: based on the transport experience of 6 cases of severe H1N1 influenza virus pneumonia on extracorporeal membrane oxygenation]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32527347. doi:10.3760/cma.j.cn121430-20200309-00413

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。